Journal of Ocular Pharmacology and Therapeutics, 2025 Inflammatory Proteins Profiling in Tear Fluid in Polypoidal Choroidal Vasculopathy and Neovascular Age-Related Macular Degeneration Chen Y., Zhang S., Zhong Q. et al. Olink Target 96OphthalmologyPathophysiologyPatient StratificationTear Fluid | | | | |
Journal of Proteome Research, 2025 A Phosphoproteomic Analysis of Mycobacterial PknG-Mediated Host Immune Evasion Baros-Steyl S., Nakedi K., Ganief T. et al. Olink Target 96Infectious DiseasesPathophysiologyCell Culture Supernatant | | | | |
Neoplasia, 2025 RANKL and CSF-1 are elevated in periovulatory follicular fluid of BRCA1 mutation carriers and increase proinflammatory signaling in fallopian tube epithelial cells Kollara A., Madaan V., Zhang J. et al. Olink Target 96OncologyPatient StratificationFollicular Fluid | | | | |
Journal of Inflammation Research, 2025 Genetic Association and Drug Target Exploration Between Inflammation-Related Proteins and the Risk of Primary Ovarian Insufficiency Wang C., Lin X., Yang X. Olink Target 96GynecologyPathophysiologyPlasma | | | | |
Aging Cell, 2025 Patterns of Organ‐Specific Proteomic Aging in Relation to Lifestyle, Diseases, and Mortality Wang Q., Huang J., He Q. et al. Olink Explore 3072/384AgingPathophysiologyPlasma | | | | |
Journal of Affective Disorders, 2025 A novel potential biomarker panel to diagnose depression derived from big proteomic data Ma S., Tan H., Zhang M. et al. Olink Explore 3072/384NeurologyPatient StratificationPlasma | | | | |
Critical Care Explorations, 2025 Aging and Host Responses to Severe Infection: Proteomic Analysis of a Prospective Multicenter Cohort From Uganda Conte Cortez Martins G., Lutwama J., Owor N. et al. Olink Target 96Infectious DiseasesAgingPathophysiologySerum | | | | |
Circulation: Heart Failure, 2025 Phenomapping in Heart Failure With Reduced Ejection Fraction to Identify Subpopulations With High Residual Risk: A VICTORIA Substudy Shah P., Zheng Y., Pieske B. et al. Olink Target 96CVDPatient StratificationPlasma | | | | |
Scientific Reports, 2025 Associations of the intestinal microbiota with plasma bile acids and inflammation markers in Crohn’s disease and ulcerative colitis Prast-Nielsen S., Granström A., Kiasat A. et al. Olink Target 96Immunological & Inflammatory DiseasesPathophysiologyPlasma | | | | |
Neurosurgical Review, 2025 Potential drug targets for intracranial aneurysms identified through Mendelian randomization analysis Peng L., Peng H., Wu N. et al. Olink Explore 3072/384CVDPathophysiologyPlasma | | | | |
British Journal of Cancer, 2025 Serum multiomics prediction of prognosis and adverse reactions to concurrent chemoradiotherapy in patients with esophageal cancer Wu W., Huang H., Zhu G. et al. Olink Target 96OncologyPatient StratificationSerum | | | | |
Journal of Proteome Research, 2025 Discovering Biomarkers for Asymptomatic Tuberculosis via Olink Proteomics and Machine Learning Sun Q., Li S., Ren W. et al. Olink Target 96Infectious DiseasesPatient StratificationPlasma | | | | |
Allergy, 2025 Dupilumab in Children Under 6 Years With Moderate‐to‐Severe Atopic Dermatitis: A 16‐Week Real‐World Prospective Study on Efficacy, Safety, and Local‐Systemic Immune Responses Zhang Y., Pi J., Wang L. et al. Olink Target 96Immunological & Inflammatory DiseasesDermatological DiseasesPathophysiologySerum | | | | |
Open Forum Infectious Diseases, 2025 Two or three? Clinical and proteomic perspectives on dolutegravir/lamivudine versus bictegravir/emtricitabine/tenofovir alafenamide as initial HIV treatment Díaz-García C., Serrano-Villar S., de Morales A. et al. Olink Target 96Infectious DiseasesPathophysiologyPlasma | | | | |
Medicine, 2025 Gut microbiota influences lung cancer risk through circulating cytokines—Insights from a Mendelian randomization study Shen W., Hou R., Zhang J. et al. Olink Target 96OncologyPathophysiologyPlasma | | | | |
The Journal of Clinical Endocrinology & Metabolism, 2025 Association of urinary copper and gestational diabetes mellitus: role of epigenome-wide DNA methylation and proteomics Li Y., Zhang S., Lai Y. et al. Olink Explore 3072/384Metabolic DiseasesEnvironmental Health & ToxicologyPathophysiologySerum | | | | |
Brain, 2025 Reference proteins to improve Core 1 and Core 2 Alzheimer’s disease CSF and plasma biomarkers Karlsson L., Janelidze S., Barthélemy N. et al. Olink Target 96NeurologyPathophysiologyCSF | | | | |
BMC Medicine, 2025 Efficacy, safety, and exploratory biomarker analysis of envafolimab plus carboplatin and etoposide as first-line treatment for extensive-stage small-cell lung cancer: a prospective, single-arm, phase II trial Zhao X., Zhang J., Qiu L. et al. Olink Target 48OncologyImmunotherapyPatient StratificationSerum | | | | |
BMC Nephrology, 2025 Association of Osteopontin and selective glomerular hypofiltration syndrome with hospitalization for kidney failure in acute heart failure patients Ohlsson M., Nilsson C., Molvin J. et al. Olink Target 96NephrologyPatient StratificationPlasma | | | | |
Current Medicinal Chemistry, 2025 Mediating Effects of Plasma Metabolites in Inflammatory Protein-Lymphoma Causality: A Mendelian Randomization Study Ji Y., Gao X., Liu L. et al. Olink Target 96OncologyPathophysiologyPlasma | | | | |